Study Shows Efficacy of Single-Cycle BEP in Preventing Testicular Cancer Recurrence

Results of this phase III trial could change the current standard of care for treating nonseminomatous or combined germ cell tumors of the testis.

Source: CancerNetwork - January 8, 2020 Category: Cancer & Oncology Authors: Kevin Wright Source Type: news